Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:34 am Sale |
2024-12-31 | 13G | Vor Biopharma Inc. VOR |
FMR CORP | 6,419,633 9.300% |
-1,199,315 (-15.74%) |
Filing History |
| 2025-01-07 4:53 pm Purchase |
2024-12-30 | 13D | Vor Biopharma Inc. VOR |
Reprogrammed Interchange LLC | 38,974,101 31.300% |
38,974,101 (New Position) |
Filing History |
| 2024-12-30 6:51 pm Purchase |
2024-12-26 | 13D | Vor Biopharma Inc. VOR |
RA Capital Management, L.P. | 39,709,850 31.900% |
16,929,507 (+74.32%) |
Filing History |
| 2024-11-14 4:33 pm Sale |
2024-09-30 | 13G | Vor Biopharma Inc. VOR |
Paradigm BioCapital Advisors LP | 0 0.000% |
-6,457,293 (Position Closed) |
Filing History |
| 2024-02-14 4:17 pm Sale |
2024-02-14 | 13D | Vor Biopharma Inc. VOR |
5AM Ventures VI L.P. | 6,361,723 9.400% |
-330,706 (-4.94%) |
Filing History |
| 2024-02-14 4:08 pm Sale |
2023-12-31 | 13G | Vor Biopharma Inc. VOR |
Paradigm BioCapital Advisors LP | 6,457,293 9.500% |
-20,706 (-0.32%) |
Filing History |
| 2024-02-09 10:05 am Sale |
2024-02-08 | 13G | Vor Biopharma Inc. VOR |
FMR CORP | 7,618,948 11.236% |
-351,563 (-4.41%) |
Filing History |
| 2023-08-11 5:05 pm Purchase |
2023-08-10 | 13D | Vor Biopharma Inc. VOR |
RA Capital Management, L.P. | 22,780,343 33.700% |
20,198 (+0.09%) |
Filing History |
| 2023-02-14 4:55 pm Purchase |
2022-12-31 | 13G | Vor Biopharma Inc. VOR |
Paradigm BioCapital Advisors LP | 6,477,999 9.900% |
4,149,505 (+178.21%) |
Filing History |
| 2023-01-10 12:48 pm Purchase |
2023-01-09 | 13G | Vor Biopharma Inc. VOR |
FMR CORP | 7,970,511 12.141% |
4,789,048 (+150.53%) |
Filing History |
| 2022-12-09 4:31 pm Purchase |
2022-12-07 | 13D | Vor Biopharma Inc. VOR |
RA Capital Management, L.P. | 22,760,145 34.800% |
11,628,845 (+104.47%) |
Filing History |
| 2022-11-14 4:46 pm Purchase |
2022-11-10 | 13D | Vor Biopharma Inc. VOR |
RA Capital Management, L.P. | 11,131,300 28.780% |
10,327 (+0.09%) |
Filing History |
| 2022-10-27 4:47 pm Purchase |
2022-10-17 | 13G | Vor Biopharma Inc. VOR |
Paradigm BioCapital Advisors LP | 2,328,494 6.100% |
2,328,494 (New Position) |
Filing History |
| 2022-02-09 10:01 am Sale |
2022-02-08 | 13G | Vor Biopharma Inc. VOR |
FMR CORP | 3,181,463 8.531% |
-753,775 (-19.15%) |
Filing History |
| 2021-03-10 09:46 am Purchase |
2021-03-09 | 13G | Vor Biopharma Inc. VOR |
FMR CORP | 3,935,238 10.601% |
3,935,238 (New Position) |
Filing History |
| 2021-02-19 4:35 pm Purchase |
2021-02-09 | 13D | Vor Biopharma Inc. VOR |
5AM Ventures VI L.P. | 6,692,429 18.000% |
6,692,429 (New Position) |
Filing History |
| 2021-02-19 4:30 pm Purchase |
2021-02-09 | 13D | Vor Biopharma Inc. VOR |
RA Capital Management, L.P. | 11,120,973 30.000% |
11,120,973 (New Position) |
Filing History |